14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 3rd May 2024 ABUS stock ended at $2.71. This is 1.12% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.56% from a day low at $2.70 to a day high of $2.85.
90 days $2.30 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Jan 18, 2022 $3.26 $3.31 $3.06 $3.07 3 381 300
Jan 14, 2022 $3.16 $3.32 $3.13 $3.31 2 453 200
Jan 13, 2022 $3.33 $3.34 $3.22 $3.22 2 437 200
Jan 12, 2022 $3.36 $3.39 $3.27 $3.30 2 107 600
Jan 11, 2022 $3.50 $3.52 $3.35 $3.36 2 879 900
Jan 10, 2022 $3.53 $3.59 $3.38 $3.52 2 234 000
Jan 07, 2022 $3.56 $3.62 $3.46 $3.50 1 760 200
Jan 06, 2022 $3.50 $3.61 $3.40 $3.56 2 888 700
Jan 05, 2022 $3.76 $3.77 $3.52 $3.53 2 660 500
Jan 04, 2022 $3.94 $3.95 $3.65 $3.73 4 014 885
Jan 03, 2022 $3.89 $4.01 $3.78 $3.98 2 222 910
Dec 31, 2021 $3.86 $4.03 $3.84 $3.89 2 914 648
Dec 30, 2021 $3.77 $3.91 $3.74 $3.88 2 720 182
Dec 29, 2021 $3.79 $3.86 $3.70 $3.76 3 167 264
Dec 28, 2021 $3.85 $4.01 $3.78 $3.82 3 677 606
Dec 27, 2021 $4.16 $4.16 $3.85 $3.86 4 450 429
Dec 23, 2021 $4.13 $4.24 $4.00 $4.16 4 364 162
Dec 22, 2021 $4.33 $4.33 $4.13 $4.16 3 088 077
Dec 21, 2021 $4.38 $4.46 $4.27 $4.29 3 606 423
Dec 20, 2021 $4.17 $4.50 $4.14 $4.38 7 434 006
Dec 17, 2021 $3.85 $4.34 $3.78 $4.28 7 839 711
Dec 16, 2021 $4.07 $4.15 $3.88 $3.89 4 531 898
Dec 15, 2021 $4.12 $4.12 $3.80 $4.09 5 178 243
Dec 14, 2021 $4.25 $4.58 $4.02 $4.14 8 353 291
Dec 13, 2021 $4.38 $4.50 $4.14 $4.36 7 765 667
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT